ALKERMES reported $293.9M in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acorda Therapeutics ACOR:US USD 187.69M 2.71M
Amgen AMGN:US USD 38.7B 2.18B
Biogen BIIB:US USD 6.28B 998M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Coherus Biosciences CHRS:US USD 245.25M 175.72M
Eli Lilly And LLY:US USD 15.89B 925.4M
Heron Therapeutics HRTX:US USD 149.23M 52K
Horizon Pharma HZNP:US USD 2.57B 1.85M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
JAZZ PHA JAZZ:US USD 5.73B 294.18M
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Otsuka Holdings 4578:JP JPY 205.56B 3.48B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Revance Therapeutics RVNC:US USD 388.28M 7.82M
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M